Sign in

CIK 0001355790

  • Non-accelerated filer
  • Smaller reporting company

International Stem Cell CORP

Sign in to watch
Ticker
ISCO
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
204494098
Phone
+1 760-940-6383
Business address
9745 BUSINESSPARK AVENUE, SAN DIEGO, CA, 92131
Former names
BTHC III INC.
  1. 4 Open-market buy Dir. of Legal Affairs & Oper. bought 10,000 shares at $0.10 ($1,000)
  2. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.10 ($1,000)
  3. 4 Open-market buy Executive Vice President bought 10,000 shares at $0.10 ($1,000)
  4. 4 Open-market buy Chief Scientific Officer bought 555,556 shares at $0.09 ($50,000)
  5. 4 Open-market buy Chief Executive Officer bought 3,888,889 shares at $0.09 ($350,000)
  6. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.10 ($1,000)
  7. 4 Open-market buy Executive Vice President bought 10,000 shares at $0.10 ($1,000)
  8. 4 Open-market buy Dir. of Legal Affairs & Oper. bought 10,000 shares at $0.10 ($1,000)
  9. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.10 ($1,000)
  10. 4 Open-market buy Executive Vice President bought 10,000 shares at $0.10 ($1,000)
  11. 4 Open-market buy Dir. of Legal Affairs & Oper. bought 10,000 shares at $0.10 ($1,000)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Chief Scientific Officer bought 1,000,000 shares at $0.10 ($100,000)
  14. 4 Open-market buy Chief Executive Officer bought 5,000,000 shares at $0.10 ($500,000)
  15. 4 Open-market buy Chief Scientific Officer bought 700,000 shares at $0.10 ($70,000)
  16. 4 Open-market buy Chief Executive Officer bought 4,800,000 shares at $0.10 ($480,000)
  17. 4 Exercise or conversion Chief Scientific Officer acquired 1,601,200 shares (option exercise)
  18. 4 Exercise or conversion Chief Executive Officer acquired 10,504,584 shares (option exercise)
  19. 4 Open-market buy Chief Scientific Officer bought 463,333 shares at $0.15 ($69,500)
  20. 4 Open-market buy Chief Executive Officer bought 2,870,000 shares at $0.15 ($430,500)

Page 9 of 19 · 362 filings